Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people
A University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response.
Apr 1, 2021
0
5